UPDATE: Teva Pharma (TEVA) Tops Q4 EPS by 1c, Offers FY20 Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Teva Reports Fourth Quarter and Full Year 2019 Financial Results
February 12, 2020 7:00 AM ESTTEL AVIV, Israel--(BUSINESS WIRE)-- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today reported results for the year and the quarter ended December 31, 2019.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200212005398/en/
Full-Year 2019 and Q4 2019... More
